Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Buy Walgreen Company (WAG) Stock After the Q3 Miss?

Ouch. If you own Walgreen Company (NYSE:WAG) stock, you’re likely feeling some pain after Tuesday’s drop of nearly 6%. Shares fell the most in months on news that the big pharmacy chain missed the consensus earnings estimates for its fiscal 2013 third quarter. Does the pullback present a good opportunity to buy the stock? Let’s take a look.

Walgreen Company (NYSE:WAG)

Behind the miss
Analysts expected adjusted earnings of $0.91 per share. Walgreen actually reported $0.85 per share.

CEO Greg Wasson said that “front-end sales are still not up to our expectations.” This was borne out in Walgreen Company (NYSE:WAG) reporting a 3.9% decline in customer traffic in stores open at least for a year. Total sales in these stores increased by a meager 1.4% year over year.

Wasson attributes some of the disappointment to weather, which affected sales negatively during the quarter. He also noted continuing effects of the sluggish economy. Economic woes particularly affected Walgreen stores in lower-income areas, which have generally performed below the levels of its stores in middle- and higher-income communities.

The aftermath of the dispute with Express Scripts Holding Company (NASDAQ:ESRX) also continues to play a factor for Walgreen Company (NYSE:WAG). After the two sides couldn’t come to an agreement, Walgreen allowed its contract with Express Scripts to expire at the end of 2011.

That move didn’t go so well for the pharmacy chain, though. The companies ended up signing a new multiyear agreement by mid-2012. However, many customers left Walgreen during the first half of the year. Not all have come back.

Rest of the results
Outside of the earnings miss, how do Walgreen Company (NYSE:WAG)’s quarterly results look? The company posted sales of $18.3 billion, an increase of 3.2% compared to the same quarter in the prior year.

GAAP diluted earnings came in at $0.65 per share. That reflects improvement over the $0.62 per share reported in the fiscal 2012 third quarter. Walgreen reported GAAP net income of $1.79 billion, up 1.1% year-over-year.

Although the company missed estimates, the adjusted earnings of $812 million. That reflects a 29.3% increased compared to the same quarter last year.

Walgreen Company (NYSE:WAG) also opened or acquired 39 new stores during the quarter. During the third quarter of fiscal 2012, the company counted 52 new stores.

Looking ahead
Walgreen has several things going for it. The company, along with partner Alliance Boots, announced a 10-year agreement with AmerisourceBergen Corp. (NYSE:ABC) in March. Under the terms of the deal, AmerisourceBergen will distribute branded pharmaceutical products to Walgreen stores and eventually generic drugs.

This arrangement, on top of the current partnership with Alliance Boots, should enable Walgreen Company (NYSE:WAG) to achieve operational efficiencies that it couldn’t do on its own. It also allows Walgreen and Alliance Boots to pick up a minority stake in AmerisourceBergen Corp. (NYSE:ABC).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.